[#item_full_content] [[{“value”:”Why Trulieve Cannabis Earnings Matter For Investors Now
Trulieve Cannabis (TRLV) reported second quarter 2026 results on 7 August that combined a larger net loss with lower sales, while still funding expansion in key medical cannabis markets.
The company posted revenue of US$271 million for the quarter compared with US$302.1 million a year earlier, and reported a net loss of US$406 million versus US$13.8 million in the prior year period.
See our latest analysis for Trulieve Cannabis.
Trulieve…”}]] Read More
Trulieve Cannabis (TRLV) Could Be 55% Undervalued On Weak Q2 Earnings
ByPot Shop News
August 10, 2026